Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages
about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenImmunotherapy for cancer in the central nervous system: Current and future directionsImmune Evasion Strategies of GlioblastomaImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesThe role of IDO in brain tumor immunotherapyMolecular biology of high-grade gliomas: what should the clinician know?Immunotherapy for brain cancer: recent progress and future promiseCombining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System MalignanciesTargeting immune checkpoints in malignant gliomaPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Prospects of immune checkpoint modulators in the treatment of glioblastomaClinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy.PD-1, PD-L1, PD-L2 expression in the chordoma microenvironmentImmunocompetent murine models for the study of glioblastoma immunotherapyAssessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBMBu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cellsIntravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma modelCryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes.PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsSerum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival timeProgrammed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic dietPI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages.Immunosuppressive mechanisms in glioblastoma.PD-L1 expression in papillary renal cell carcinomaTherapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.PD-L1 expression and prognostic impact in glioblastoma.MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsCD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.Natural killer cells require monocytic Gr-1(+)/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cellsRecent advances and future of immunotherapy for glioblastoma.Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles.Advances in Immunotherapy for Glioblastoma Multiforme.IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination.Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy.Microenvironmental clues for glioma immunotherapy.
P2860
Q26749972-F49501DB-F5A3-4BE1-BBB9-A91391E3E6C2Q26750765-19AC5434-B601-4E1F-B231-87FC03E718DDQ26765855-626BB415-02A0-4BA3-8ABE-ACA55465FBEFQ26798402-94FB7796-4D32-4180-B7A1-B24EAD8F3C1EQ26830399-8F0E03E4-E545-405A-BB83-2A406039D937Q27009190-78BDF6ED-C071-49AD-9642-B222880CFE77Q27015881-8DA87A5C-C2D0-4D5B-A99D-D8E61474EB58Q28072007-B10C56DB-FF40-432C-BEB6-2B21D3938A6EQ28072012-CD3CE6CC-66E9-4860-B904-B829FA44A6BDQ28076161-69B95282-3F14-470B-9BE8-12F8C104ED2BQ28078539-FFE7EDF6-49AD-440A-92B0-C650F87FEACDQ28081371-FC29577A-8DB7-46FB-A538-9040AD93383CQ28084351-4110EE04-041A-4729-8B8C-8227102B65A9Q30916013-F0D9A2CF-8FF9-4FDE-B856-75892D0E3993Q33275412-3F3A683A-AD2B-4E12-A387-8ECE9968DE9DQ33574853-924344C8-F4E4-41AF-926E-2E20E6E839B8Q33578030-020A76AB-AF2C-4E38-BC52-E063649AC711Q33788049-C04A925D-8E44-47BA-B0DF-3B5E1590C6B3Q35018554-CDB021CC-DB3B-4983-8B1D-FC20A64F68E2Q35077635-326A7570-2C4C-4D16-930B-3E003BE5D23EQ35184986-F54C0293-1EE3-4B84-BD6A-CD749FD320BAQ35677709-B0C16AF1-1D45-49F8-ACC7-AD2296B04F4CQ35772513-59D8FB81-88AA-47B9-896B-B59F950B45D8Q35815273-09113354-8BDF-47B7-B498-D9DDA8E493D3Q36017728-72DB0DC0-85F5-4292-88F9-1ABABC856A35Q36086507-49E6B036-E3F2-456F-A441-99C58AE128BAQ36107956-1900B9C3-5925-4B51-ACCA-B00B20B8A7F2Q36224048-606A11B3-DCAF-4B3E-930C-5D0B965CB521Q36249417-A6D5EE38-E3D9-46CA-891D-8C3BDACFDF0EQ36416387-E8EFD7DB-8529-444A-AE74-873E40279A0EQ36493843-8DBDCDAD-849D-46BC-ACEB-464A960C8421Q36785139-3E8CBDEA-2B5F-43DA-84D5-153D6A32831BQ36893225-5A40AC55-F065-4DF8-896B-F0A91CD0F642Q37079098-5D8F201A-5A4E-426B-B198-E29B240F8C26Q37239071-F70C1B2F-C8A3-48A5-BCA7-D24CED3DD178Q37616489-2D946200-BB29-4216-936F-65A3A6E55E84Q37680966-8A795D0F-82D9-45A3-9CB8-E313C01228E9Q37709350-0F75CF38-DCBE-416A-A71A-22FCD46123C9Q37741143-EF1D0E02-1124-4A76-A379-DBF55BAAF46CQ38194054-6881FEDE-FF8D-4450-9F43-9C852C85C863
P2860
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gliomas promote immunosuppress ...... n tumor-associated macrophages
@en
Gliomas promote immunosuppress ...... tumor-associated macrophages.
@nl
type
label
Gliomas promote immunosuppress ...... n tumor-associated macrophages
@en
Gliomas promote immunosuppress ...... tumor-associated macrophages.
@nl
prefLabel
Gliomas promote immunosuppress ...... n tumor-associated macrophages
@en
Gliomas promote immunosuppress ...... tumor-associated macrophages.
@nl
P2093
P2860
P1476
Gliomas promote immunosuppress ...... n tumor-associated macrophages
@en
P2093
Andrew T Parsa
Courtney A Crane
Martin J Rutkowski
Michael Safaee
Orin Bloch
Rajwant Kaur
P2860
P304
P356
10.1158/1078-0432.CCR-12-3314
P407
P577
2013-04-23T00:00:00Z